Hexarelin vs GHRP-2

Side-by-side comparison of Hexarelin, GHRP-2 — mechanism, dosing, half-life, side effects, and research status.

← Pick different peptides
Attribute Hexarelin Hexarelin (Examorelin) Growth Hormone GHRP-2 Growth Hormone Releasing Peptide-2 Growth Hormone
Basics
Molecular type Growth Hormone Releasing Peptide (GHRP)Growth Hormone Releasing Peptide (GHRP)
Amino acids 66
Molecular weight 887.1 Da817.9 Da
Half-life ~2 hours~1–2 hours
Route(s) Subcutaneous, Intramuscular, IntranasalSubcutaneous, Intramuscular, Intranasal
Mechanism & Research
Primary mechanism Hexarelin activates GHSR-1a with exceptionally high potency, producing GH pulse amplitudes that exceed GHRP-2 and GHRP-6 at equivalent doses. It also acts at the hypothalamic level to suppress somatostatin, contributing … GHRP-2 activates the ghrelin receptor (GHSR-1a) in the pituitary and hypothalamus. Hypothalamic activation leads to reduced somatostatin tone (the GH release inhibitor), while pituitary activation directly triggers GH se…
Research status Research Compound Research Compound
Evidence summary Hexarelin has Phase 1/2 clinical data including cardiac research. Its direct cardioprotective mechanism is one of the most distinctive features of any GHRP. Research also supports its use in GH deficiency testing. GHRP-2 has been extensively studied in humans including as a diagnostic tool for GH deficiency assessment. Its well-characterised dose-response relationship makes it a reference compound in the GHRP class.
Protocol & Dosing
Typical dose 100–200 mcg per injection100–200 mcg per injection
Frequency 2× daily2–3x daily
Duration 4–6 weeks maximum (desensitisation concern)8–12 weeks
Timing Fasted stateFasted state; 2+ hours post-meal
Safety
Common side effects
  • Cortisol elevation (significant at higher doses)
  • Prolactin increase
  • Rapid receptor desensitisation
  • Water retention
  • Cortisol elevation (dose-dependent)
  • Prolactin increase (transient)
  • Increased appetite
  • Water retention
Contraindications
  • Active malignancy
  • Cardiac conditions (paradoxical concern despite cardiac data — consult cardiologist)
  • Pregnancy
  • Active malignancy
  • Hypothyroidism
  • Pregnancy
Anti-doping Prohibited (WADA S2) Prohibited (WADA S2)
Deeper reading
Related peptides GHRP-2, GHRP-6, Ipamorelin Ipamorelin, CJC-1295, GHRP-6, Hexarelin
Full profile Read full Hexarelin profile → Read full GHRP-2 profile →

Comparison data is compiled from each peptide’s individual profile. All values are drawn from peer-reviewed research and regulatory sources. For educational use only — not medical advice. Verify any protocol with a qualified healthcare provider.